NeoGenomics, Inc. Common Stock, Capital Shares Reserved for Future Issuance
NeoGenomics, Inc. (NEO) had Common Stock, Capital Shares Reserved for Future Issuance of 33.92 million shares as of 2023-05-25, per its 10-K filed 2026-02-17.
Financial Statements › Notes › Stockholders' Equity Note › Class of Stock Disclosures
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-02-17
- 2023-05-25: Common Stock, Capital Shares Reserved for Future Issuance 33.92M shares; Common Stock, Capital Shares Reserved for Future Issuance as first filed 29.60M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance | Common Stock, Capital Shares Reserved for Future Issuance as first filed |
|---|---|---|
| 2023-05-25 | 33.92M shares 10-K · filed 2026-02-17 | 29.60M shares 10-K · filed 2024-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |